BioVerde Tech
develops engineered methanotroph strains that convert methane into chemical intermediates and protein-rich biomass, holding multiple granted and pending US patents on methane-to-multi-carbon-compound biological conversion;…
- Country
- United States
Granted US patents
us
Coverage
| EU | US | |
|---|---|---|
| platform-chemicals | ✓ | ✓ |
Regulatorsreachepa
Technologies
| Name | Cluster | Risk | |
|---|---|---|---|
| Biosynthetic butadiene | platform-chemicals | High | → |
Compiled by BIOECON via the bioecon-brief pipeline.
Compliance
Bioecon is an information intermediary; it is not a regulator, a certification body, or a legal advisor. When working with public-sector customers (procurement under 44-FZ / 223-FZ), Bioecon acts solely as an independent analytical platform, with no remuneration from suppliers.